Corrigendum to: 2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia [Eur Heart J (2017)

Ulf Landmesser, M. John Chapman, Jane K. Stock, Pierre Amarenco, Jill Belch, Jan Borén, Michel Farnier, Brian A. Ference, Stephan Gielen, Ian Graham, Diederick E. Grobbee, G. Kees Hovingh, Thomas F. Luscher, Massimo Piepoli, Kausik K. Ray, Erik S. Stroes, Olov Wiklund, Stephan Windecker, Jose Luis Zamorano, Fausto PintoLale Tokgozoglu, Jeroen J. Bax, Alberico L. Catapano

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)
Original languageEnglish
Article numberehx648
Pages (from-to)1-1
Number of pages1
JournalEuropean Heart Journal
Publication statusPublished - 24 Nov 2017

Cite this